SENSIENT TECHNOLOGIES ($SXT) posted quarterly earnings results on Friday, July 25th. The company reported earnings of $0.94 per share, beating estimates of $0.89 by $0.05. The company also reported revenue of $414,230,000, missing estimates of $421,574,000 by $-7,344,000.
You can see Quiver Quantitative's $SXT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SENSIENT TECHNOLOGIES Insider Trading Activity
SENSIENT TECHNOLOGIES insiders have traded $SXT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SXT stock by insiders over the last 6 months:
- MARIO FERRUZZI sold 1,668 shares for an estimated $159,214
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SENSIENT TECHNOLOGIES Hedge Fund Activity
We have seen 123 institutional investors add shares of SENSIENT TECHNOLOGIES stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORDEA INVESTMENT MANAGEMENT AB removed 708,352 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $52,722,639
- BAYBERRY CAPITAL PARTNERS LP added 384,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $28,581,120
- MARSHALL WACE, LLP added 235,653 shares (+68.6%) to their portfolio in Q1 2025, for an estimated $17,539,652
- BANK OF AMERICA CORP /DE/ added 223,700 shares (+441.4%) to their portfolio in Q1 2025, for an estimated $16,649,991
- ARMISTICE CAPITAL, LLC added 199,827 shares (+57.1%) to their portfolio in Q1 2025, for an estimated $14,873,123
- BLACKROCK, INC. removed 159,490 shares (-2.4%) from their portfolio in Q1 2025, for an estimated $11,870,840
- CRAMER ROSENTHAL MCGLYNN LLC added 151,167 shares (+inf%) to their portfolio in Q1 2025, for an estimated $11,251,359
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SENSIENT TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $SXT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 07/03/2025
To track analyst ratings and price targets for SENSIENT TECHNOLOGIES, check out Quiver Quantitative's $SXT forecast page.
SENSIENT TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $SXT recently. We have seen 2 analysts offer price targets for $SXT in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Ghansham Panjabi from Baird set a target price of $125.0 on 07/03/2025
- Larry Solow from CJS Securities set a target price of $95.0 on 06/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
